Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

154
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
154
Randomized Experiments01:13

Randomized Experiments

8.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.8K
One-Way ANOVA: Equal Sample Sizes01:15

One-Way ANOVA: Equal Sample Sizes

4.0K
One-Way ANOVA can be performed on three or more samples with equal or unequal sample sizes. When one-way ANOVA is performed on two datasets with samples of equal sizes, it can be easily observed that the computed F statistic is highly sensitive to the sample mean.
Different sample means can result in different values for the variance estimate: variance between samples. This is because the variance between samples is calculated as the product of the sample size and the variance between the...
4.0K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

198
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
198
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

531
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
531
One-Way ANOVA01:18

One-Way ANOVA

11.8K
One-way ANOVA analyzes more than three samples categorized by one factor. For example, it can compare the average mileage of sports bikes. Here, the data is categorized by one factor - the company. However, one-way ANOVA cannot be used to simultaneously compare the sample mean of three or more samples categorized by two factors. An example of two factors would be sports bikes from different companies driven in different terrains, such as a desert or snowy landscape. Here, two-way ANOVA is used...
11.8K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Integration of aggregate data in causally interpretable meta-analysis by inverse weighting.

Biometrics·2026
Same author

IV-learner: learning conditional average treatment effects using instrumental variables.

Biostatistics (Oxford, England)·2026
Same author

Two stage least squares with time-varying instruments: An application to an evaluation of treatment intensification for type-2 diabetes.

Statistical methods in medical research·2025
Same author

Orthogonal prediction of counterfactual outcomes.

Journal of causal inference·2025
Same author

All Lines Is the Right Approach: Selecting Patient Lines of Therapy for an External Comparator Arm.

Pharmacoepidemiology and drug safety·2025
Same author

Causal Machine Learning Methods and Use of Cross-Fitting in Settings With High-Dimensional Confounding.

Statistics in medicine·2025
Same journal

Statistical analysis of disease onset during lifespan with left truncation.

Biometrics·2026
Same journal

Interim analysis in sequential multiple assignment randomized trials for survival outcomes.

Biometrics·2026
Same journal

Acknowledgment of Referees 2025.

Biometrics·2026
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
関連記事をすべて見る

関連する実験動画

Updated: Jan 8, 2026

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.3K

異質な治療効果のための変数重要度指標

Oliver J Hines1, Karla Diaz-Ordaz2, Stijn Vansteelandt3

  • 1Department of Epidemiology, Columbia University, New York, NY 10032, United States.

Biometrics
|December 24, 2025
PubMed
まとめ
この要約は機械生成です。

治療効果の異質性を駆動する主要因を特定するための新しい手法を開発しました。これらの治療効果変数重要度指標（TE-VIM）は、個別化医療における複雑な機械学習モデルの理解に役立ちます。

キーワード:
因果推論条件付き効果データ適応的推定効果修飾

さらに関連する動画

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.7K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K

関連する実験動画

Last Updated: Jan 8, 2026

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.3K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.7K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K

科学分野:

  • 生物統計学
  • 機械学習
  • 個別化医療

背景:

  • 個別化医療において条件付き平均治療効果（CATE）を推定することは非常に重要です。
  • 機械学習（ML）を使用した現在のCATEモデルは複雑であり、異質性ドライバーに関する解釈可能性が欠けている可能性があります。

研究 の 目的:

  • 治療効果の異質性の主要因を特定するためのノンパラメトリック治療効果変数重要度指標（TE-VIM）を導入すること。
  • 様々なCATE推定戦略およびML技術と互換性のあるTE-VIMの効率的な推定量を開発すること。

主な方法:

  • 変数を除外した際の平均二乗誤差（MSE）の増加に基づいてTE-VIMを提案しました。
  • ML推定に適応可能な効率的なTE-VIM推定量を開発しました。
  • 一般的なメタ学習者を使用した、Leave-one-outおよびKeep-one-inなどの計算戦略を調査しました。

主要な成果:

  • シミュレーション研究を通じてTE-VIMの有限サンプル性能を実証しました。
  • 実際の臨床試験データを使用してTE-VIMの実用的な応用を説明しました。

結論:

  • TE-VIMは、複雑なCATEモデルを解釈し、治療異質性のドライバーを特定するための堅牢な方法を提供します。
  • 提案された手法は、治療効果に関する解釈可能な洞察を提供することにより、個別化医療におけるMLの有用性を高めます。